GLS and acute myeloid leukemia: Finally, the high metabolic plasticity of AML cells, encompassing upregulation of alternative substrate transporters or compensatory pathways like fatty acid oxidation or micropinocytosis, could limit long-term efficacy of glutaminase targeting, emphasizing the need for rationally designed combination regimens that balance metabolic targeting, antileukemic potency, and tolerability.